Patients with diabetic CKD (CKD type 1) and those with nephrosclerosis (CKD type 2) exhibited equally higher s-CSF2-Ab and s-CSF2pep-Ab levels than the HDs (Figures 4A, B). Here, CSF2 is linked to nephrosclerosis.